Biocept Announces New Executive Hires to its Sales and Marketing Organization
"I am pleased to announce the hiring of Cory and Scott, as we restructure and refocus the sales and marketing organization at
Nicholson is a veteran sales executive in the medical lab industry with experience in the oncology segment. His previous positions ranged from Sales Executive, District Manager, and Regional Manager to Vice President of Sales and Senior Vice President of Sales. Nicholson was the first sales representative hired at
Dunn most recently served as Vice President of Commercial Marketing at GenomeDx, where she led the launch, commercial marketing, and product life cycle management of the Decipher® genomic suite of tests for urologic cancers. Prior to GenomeDx, Dunn oversaw the marketing efforts for PLUS Diagnostics' Gastroenterology, Dermatology and Hematology-Oncology product lines, which produced record growth rates and culminated in nearly
Inducement Awards
In connection with the hiring of Nicholson and Dunn,
In addition, in connection with the hiring of an individual to the position of Product Specialist,
Each of the stock options described above was granted as an inducement material to entering into employment with
About
Forward-Looking Statements Disclaimer Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this release are not strictly historical, including without limitation statements as to our ability to improve the outcomes of patients diagnosed with cancer, our ability to build upon our market presence in the liquid biopsy segment, and our ability to reaccelerating sales of our Target Selector assay platform, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our
Investor Contact: |
Media Contact: |
LHA Investor Relations |
Trevelino/Keller |
Jody Cain |
Colleen Murphy |
310-691-7100 |
404-214-0722, Ext. 109 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/biocept-announces-new-executive-hires-to-its-sales-and-marketing-organization-300743399.html
SOURCE